Kukje Pharma Co., Ltd. (002720.KS)
KRW 4970.0
(-2.17%)
KRW 4970.0
(-2.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 135.37 Billion | 126.58 Billion | 119.74 Billion | 130.39 Billion | 111.12 Billion | 107.68 Billion |
| Cost of Revenue | 68.14 Billion | 63.32 Billion | 65.27 Billion | 65.59 Billion | 58.13 Billion | 58.87 Billion |
| Gross Profit | 67.22 Billion | 63.25 Billion | 54.47 Billion | 64.8 Billion | 52.98 Billion | 48.8 Billion |
| Operating Expenses | 69.21 Billion | 57.98 Billion | 56.14 Billion | 58.76 Billion | 47.41 Billion | 45.52 Billion |
| Selling, General and Administrative Expenses | 65.45 Billion | 27.57 Billion | 26.32 Billion | 21.16 Billion | 17.28 Billion | 16.48 Billion |
| Research and Development Expenses | 5.04 Billion | 1.96 Billion | 2.77 Billion | 3.03 Billion | 2.6 Billion | 3.59 Billion |
| Other Expenses | - | 28.43 Billion | 27.04 Billion | 34.56 Billion | 27.52 Billion | 562.36 Million |
| Cost and Expenses | 137.36 Billion | 121.31 Billion | 121.42 Billion | 124.35 Billion | 105.55 Billion | 104.39 Billion |
| Operating Income | -1.98 Billion | 5.27 Billion | -401.29 Million | 6.04 Billion | 925.93 Million | 3.28 Billion |
| Interest Expense | 1.43 Billion | 1 Billion | 696.43 Million | 650.12 Million | 862.98 Million | 900.56 Million |
| Income Tax Expense | 1.73 Billion | 1.2 Billion | 445.53 Million | 3.39 Billion | 4.88 Billion | 647.36 Million |
| Earnings before Tax | -6.68 Billion | 4.74 Billion | -1.11 Billion | 5.59 Billion | 121.44 Million | 2.83 Billion |
| Net Income | -8.41 Billion | 3.55 Billion | -1.55 Billion | 2.2 Billion | -4.76 Billion | 2.19 Billion |
| Earnings Per Share Basic | -415.49 | 175.58 | -76.77 | 103.50 | -234.89 | 108.07 |
| Earnings Per Share Diluted | -415.49 | 175.58 | -76.77 | 103.50 | -234.89 | 107.98 |
| Weighted Average Shares Outstanding | 20.25 Million | 20.26 Million | 20.26 Million | 21.28 Million | 20.27 Million | 20.28 Million |
| Weighted Average Shares Outstanding (Diluted) | 20.25 Million | 20.26 Million | 20.26 Million | 21.28 Million | 20.27 Million | 20.3 Million |
| Gross Margin | 0.50 | 0.50 | 0.45 | 0.50 | 0.48 | 0.45 |
| EBIT Margin | -0.01 | 0.09 | 0.03 | 0.07 | 0.04 | 0.07 |
| Profit Margin | -0.06 | 0.03 | -0.01 | 0.02 | -0.04 | 0.02 |
| EBITDA | -1.03 Billion | 9.76 Billion | 4.07 Billion | 9.66 Billion | 8.81 Billion | 6.02 Billion |
| Earnings Before Tax Margin | -0.01 | 0.04 | -0.00 | 0.05 | 0.01 | 0.03 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 37.64 Billion | 37.53 Billion | 135.37 Billion | 35.29 Billion | 32.12 Billion | 35.54 Billion |
| Cost of Revenue | 18.18 Billion | 16.73 Billion | 68.9 Billion | 18.1 Billion | 16.48 Billion | 17.33 Billion |
| Gross Profit | 19.46 Billion | 20.79 Billion | 66.46 Billion | 17.19 Billion | 15.63 Billion | 18.21 Billion |
| Operating Expenses | 18.77 Billion | 17.4 Billion | 68.45 Billion | 18.6 Billion | -18.9 Billion | 16.78 Billion |
| Selling, General and Administrative Expenses | 17.45 Billion | 16.38 Billion | - | 18.14 Billion | 18.9 Billion | 16.78 Billion |
| Research and Development Expenses | 1.31 Billion | 1.01 Billion | - | 459.35 Million | 724.04 Million | 719.91 Million |
| Other Expenses | -18.86 Billion | 138.27 Million | -2.24 Billion | 2.67 Billion | -37.81 Billion | -5.19 Billion |
| Cost and Expenses | 36.95 Billion | 34.13 Billion | 137.36 Billion | 36.71 Billion | 16.48 Billion | 17.33 Billion |
| Operating Income | 683.85 Million | 3.39 Billion | -1.98 Billion | -1.41 Billion | -3.27 Billion | 1.42 Billion |
| Interest Expense | 318.44 Million | 357.4 Million | 1.43 Billion | 367.53 Million | 363.18 Million | 361.67 Million |
| Income Tax Expense | 121.65 Million | 705.24 Million | 1.73 Billion | -582.48 Million | -640.96 Million | 2.54 Billion |
| Earnings before Tax | 722.12 Million | 3.45 Billion | -6.68 Billion | -972.3 Million | -3.23 Billion | -3.72 Billion |
| Net Income | 597.39 Million | 2.74 Billion | -8.41 Billion | -389.14 Million | -2.59 Billion | -6.26 Billion |
| Earnings Per Share Basic | 29.34 | 135.04 | - | -19.22 | -128.08 | -309.37 |
| Earnings Per Share Diluted | 29.34 | 135.04 | - | -19.22 | -128.08 | -309.37 |
| Weighted Average Shares Outstanding | 20.36 Million | 20.35 Million | 20.25 Million | 20.25 Million | 20.25 Million | 20.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 20.36 Million | 20.35 Million | 20.25 Million | 20.25 Million | 20.25 Million | 20.25 Million |
| Gross Margin | 0.52 | 0.55 | 0.49 | 0.49 | 0.49 | 0.51 |
| EBIT Margin | 0.04 | 0.11 | - | -0.01 | 0.49 | 0.51 |
| Profit Margin | 0.02 | 0.07 | -0.06 | -0.01 | -0.08 | -0.18 |
| EBITDA | 1.49 Billion | 4.21 Billion | - | -472.29 Million | 15.63 Billion | 18.21 Billion |
| Earnings Before Tax Margin | 0.02 | 0.09 | -0.01 | -0.04 | -0.10 | 0.04 |
4512
N3IA
6002
NEWBRY
688305
VANTI